Home : Health : Cancer :

Cancer

7 questions on cancer gene testing

Angelina Jolie's case highlights the importance of knowing …

Angelina Jolie says she had double mastectomy

Angelina Jolie has double mastectomy

Angelina Jolie says that she has had a preventive double …

Grieving dad helps kids get to chemo

Richard Nares organizes free rides to the hospital for poor …

Docs blast ethics of $100K cancer drugs

A group of more than 120 cancer researchers and physicians took…

WNYers sought for new cancer study

A new cancer prevention study is underway, and the American …

Pfizer says Torisel-Avastin failed in cancer study

No difference in disease progression

Updated: Friday, 10 Aug 2012, 4:37 PM EDT
Published : Friday, 10 Aug 2012, 4:37 PM EDT

The Associated Press

NEW YORK (AP) - Pfizer said Friday that its drug Torisel failed to help patients with a form of advanced kidney cancer when combined with Roche's drug Avastin.

The study compared renal cell carcinoma patients taking the Torisel-Avastin combination to those taking Avastin plus another cancer drug.

Patients taking the Pfizer combination did not show slower disease progression than those in the other group. Pfizer said.

Torisel is already approved as a stand-alone treatment for advanced renal cell carcinoma.

Comments

With WIVB.com's new commenting system you don't need to register. You can login with an existing Facebook, Yahoo!, Google, or Twitter account and more. If you have a WIVB.com login you can still use it in our Participate section.